Tokyo, Dec. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059889) titled 'A study using existing data and information on EUS-HGS for malignant biliary obstruction' on Nov. 30.
Study Type:
Observational
Primary Sponsor:
Institute - Gifu municipal hospital
Condition:
Condition - malignant biliary obstruction.
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to clarify optimal treatment and management strategies for EUS-HGS based on clinical data, which is expected to enhance future treatment outcomes.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who underwent EUS-HGS for malignant biliary obstruction between January 1, 2016, and March 31, 2025.
Key exclusion criteria - 1. Patients under 20 years of age
2. Patients deemed unsuitable for treatment with EUS-HGS
3. Patients otherwise considered inappropriate for inclusion at the discretion of the physician
Target Size - 200
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2016 Year 01 Month 01 Day
Date of IRB - 2025 Year 04 Month 25 Day
Anticipated trial start date - 2016 Year 01 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068485
Disclaimer: Curated by HT Syndication.
